HORIZON INTERNATIONAL SOLUTIONS SITE

Over the last 50 years there has been a steady convergence in the probability of survival and the causes of death between the wealthiest countries of the world and most living in low-middle income countries. This represents a triumph for global health and development. It is a demonstration of what should be possible for the 1 billion people living mainly in sub-Saharan Africa and South Asia. For them, convergence seems way off. And survival is seriously compromised by a combination of diseases classically associated with underdevelopment and the more recent emergence of HIV/Aids.

For almost 5 billion people globalization has been associated with increased access to knowledge and technologies that improve life's prospects. The reduction of fatalism has been replaced by a growing global awareness that the "right to health" can become a reality when governments, nongovernmental organizations and industry play their part.

Global awareness among people and governments in wealthiest countries about the need to reduce suffering for all has led to many new initiatives in just the last few years. These include new funding mechanisms to address HIV/Aids and vaccines, a global push for debt relief and better trade opportunities for the poorest countries, and recognition of how global norms that address food safety, infectious diseases and tobacco benefit all.

This journal will encourage debate and dialogue about how progress can be accelerated so as to reduce health differences in survival and quality of life that are amenable to policy and operational interventions. It will also stimulate discussion about how new and continuing threats to all can be prevented through multi-sectoral and international actions.

We will encourage an exchange of views on how the global architecture for health governance needs to changes in the light of global threats and opportunities. Over the relatively short period of the last 5 to 8 years, many new players have emerged on the global scene with additional funding and their own sets of priorities for investing in health and health research. Simultaneously, major United Nations players like the WHO, World Bank and UNICEF have changed their focus. We will stimulate discussion about how best to enhance the prospects of improving health at the local and national level through better global governance, and hope for an exchange of ideas that will be innovative and helpful to the process of improving global health.

Competing interests

There are no competing interests related to this work. But in the interests of full disclosure, Derek Yach is funded at Yale to develop community based chronic disease prevention research models internationally by Novo Nordisk.

Editorial by: Derek Yach, Yale University School of Medicine, Department of Epidemiology and Public Health, 60 College Street, Suite 319, New Haven, CT 06520-8034, USA derek.yach@yale.edu

This article has been peer reviewed by the Globalization and Health Editorial Board

Article Received: 19 April 2005

Accepted:          22 April 2005

Published:           22 April 2005     

© 2005 Yach; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

The electronic version of this article is the complete one and can be found online at: http://www.globalizationandhealth.com/content/1/1/2

Globalization and Health:

Editors-in-Chief

Greg Martin (United Kingdom)

Derek Yach (United States)

Editorial Board

Alan Berkman (United States)

Pippa Bird (United Kingdom)

Shannon Bradley (United Kingdom)

Richard Coughlin (United States)

Nick Drager (Switzerland)

Esther Freeman (United Kingdom)

Maud Huynen (Netherlands)

Chris Koddermann (United Kingdom)

James McIntyre (South Africa)

Hunter Nottage (Switzerland)

Michael Adrian Peters (United Kingdom)

Allie Sharma (United States)

Sarah Staedke (United Kingdom)

Marc Tebruggee (United Kingdom)

Eftyhia Vardas (South Africa)

James Woodcock (United Kingdom)

Welcome to Globalization and Health

Brief summary of what Open Access means for the reader:

Anyone is free:

• to copy, distribute, and display the work;
• to make derivative works;
• to make commercial use of the work;

Under the following conditions: Attribution

• the original author must be given credit;
• for any reuse or distribution, it must be made clear to others what the license terms of this work are;
• any of these conditions can be waived if the authors gives permission.

Statutory fair use and other rights are in no way affected by the above.

BioMed Central's Open Access Charter: http://www.biomedcentral.com/info/about/charter
Access to BioMed Central journals: http://www.biomedcentral.com/info/about/access